Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine (CIGB/Heber Biotec)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria/tetanus/pertussis/hepatitis B virus infection vaccine (CIGB/Heber Biotec)
Drug Alias NameTrivac HB
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[4] 
Global Approved IndicationsHepatitis BTetanusDiphtheria +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2009/12/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And BiotechnologyHeber Biotec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHepatitis BTetanusDiphtheria +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA05
Related LinksN/A